← All trials
NCT00863122
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2009
- Primary completion
- Dec 1, 2013
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- 26
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Johns Hopkins UniversityLead sponsor
- Johns Hopkins UniversityOverall official - principal investigator
- GlaxoSmithKlineCollaborator
- New York UniversityCollaborator
- Ohio State UniversityCollaborator
- House Research InstituteCollaborator
- Harvard UniversityCollaborator
- The Children's Tumor FoundationCollaborator
- Cornell UniversityCollaborator
- Washington University in St. LouisCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.